New diabetes clinical trial: A Study to Test if Trevogrumab or Trevogrumab With Garetosmab When Taken With Semaglutide is Safe and How Well They Work in Adult Patients With Obesity for Weight Loss and Fat Loss

Published on: March 06, 2024 at 11:00PM
Conditions: Obesity
Interventions: Drug: Trevogrumab-Part A; Drug: Trevogrumab-Part B; Drug: Garetosmab; Drug: Semaglutide; Drug: Matching Placebo-Part A; Drug: Matching Placebo-Trevogrumab; Drug: Matching Placebo-Garetosmab
Sponsors: Regeneron Pharmaceuticals
Not yet recruiting
https://ift.tt/mLldyH3